FIELD: organic chemistry. SUBSTANCE: product: compounds of the formula (I) where R1 hydrogen, methyl or ethyl; R2 methyl, CH2OH, CH2-OCH3 or n-propyl; R3 ethyl, propyl, allyl; R4 together with nitrogen with which it is bound forms 4-N-(R6)-piperazinyl group; R5 hydrogen and others; R6 hydrogen and others, or their pharmaceutically acceptable salts. Reagent 1: compounds of the formula (II) where Y chlorine, bromine and others. Reagent 2: compounds of the formula (III). Reaction conditions: after interaction of reagents 1 and 2 the end product is isolated or converted to the pharmaceutically acceptable form, or phenolic group is O-alkylated, or if R2 hydroxy-group then it is protected with acetyl or benzoyl group followed by its removal by hydrolysis. Synthesized compounds were used in pharmacology. EFFECT: improved method of synthesis. 2 tbl
Title |
Year |
Author |
Number |
PYRAZOLOPYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1991 |
- Ehndrju Simon Bell
- Dehvid Braun
- Nikolas Kennet Terrett
|
RU2114114C1 |
PYRAZOLOPYRIMIDINONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE |
1992 |
- Ehndrju Simon Bell
- Nikolas Kennet Terrett
|
RU2114113C1 |
PYRAZOLEPYRIMIDINONES FOR TREATMENT OF IMPOTENTS |
1994 |
- Piter Ehllis
- Nikolas Kennet Terrett
|
RU2130776C1 |
PIRAZILE PYRIMIDINONES FOR IMPOTENCY TREATMENT |
1994 |
- Ehllis Piter
- Terrett Nikolas Kennet
|
RU2373938C9 |
IMPROVED METHOD FOR PREPARING 5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-N-PROPYL-1, 6-DIHYDRO-7H-PYRAZIL[4,3-D]PYRIMIDINE-7-ONE |
2003 |
- Modi Shirish Bkhagvanlal
- Doshi Madkhukant Mansukkhlal
- Shrikande Atul Anant
|
RU2239637C1 |
PROCESS FOR PREPARING 3-QUINUCLIDINYL PROPIONIC ACID ESTERS |
1990 |
- Piter Ehdvard Kross[Gb]
- Alan Stoubi[Gb]
|
RU2005721C1 |
METHOD FOR SYNTHESIS OF CONDENSED DERIVATIVES OF PYRAZOLO-[3,4-D]-PYRIMIDINE |
0 |
- Takekhiko Naka
- Taketosi Saidzo
- Khirosi Satokh
|
SU1739850A3 |
COMPOUND POSSESSING INHIBITORY ACTION ON PHOSPHODIESTERASE TYPE 5, AND METHOD FOR PREPARING IT |
2010 |
|
RU2547465C2 |
1,2,4-TRIAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS |
1992 |
- Rodzher Piter Dikinson[Gb]
- Kennet Richardson[Gb]
|
RU2095358C1 |
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
|
RU2124016C1 |